BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 35 found
  Current Search:  testim: 35     

HTML
100%
Citi Downgrades Auxilium Pharmaceuticals (AUXL) to Hold
Citi downgrades Auxilium Pharmaceuticals Inc (Nasdaq: AUXL) from Buy to Hold.

Price target lowered from $43 to $37.

Citi analyst says, 'We believe Auxilium's Xiaflex offers patients with Dupuytren's Contracture (DC) a non-invasive, safe...

Street Insider:  Jul 24 2008 12:53PM
Matching: testim
Find similar documents
HTML
100%
Slate Pharmaceuticals raises $5 million
CEO Bob Whitehead says the pellet, which is inserted just under the skin, provides an alternative way of replacing testosterone in older men who have low levels of the hormone.

Right now, testosterone replacement is done by injection, skin...

Business Journal of Milwaukee:  Jul 21 2008 12:40PM
Matching: testim
Find similar documents
HTML
100%
Slate Pharmaceuticals raises $5 million
CEO Bob Whitehead says the pellet, which is inserted just under the skin, provides an alternative way of replacing testosterone in older men who have low levels of the hormone.

Right now, testosterone replacement is done by injection, skin...

East Bay Business Journal:  Jul 21 2008 6:23AM
Matching: testim
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Announce Second Quarter 2008 Results and Conduct Conference Call on Thursday, July
(Marketwire Via Acquire Media NewsEdge) MALVERN, PA, July 17 / MARKET WIRE/ -- Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the second quarter 2008 on Thursday, July 31,...

TMC Net:  Jul 17 2008 3:22PM
Matching: testim
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Announce Second Quarter 2008 Results and Conduct Conference Call on Thursday, July
MALVERN, PA -- (MARKET WIRE) -- 07/17/08 -- Auxilium Pharmaceuticals, Inc.

(AUXL), a specialty biopharmaceutical company, will release results for the second quarter 2008 on Thursday, July 31, 2008 before the opening of the financial...

Houston Chronicle:  Jul 17 2008 12:36PM
Matching: testim
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Announce Second Quarter 2008 Results and Conduct Conference Call on Thursday, July
LVERN, PA, July 17 / MARKET WIRE/ -- Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the second quarter 2008 on Thursday, July 31, 2008 before the opening of the financial...

Macro World Investor:  Jul 17 2008 11:36AM
Matching: testim
Find similar documents
HTML
100%
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmaceuticals to Announce Second Quarter 2008 Results and Conduct C
- Auxilium Pharmaceuticals, Inc.

(NASDAQ Mr.

Armando Anido, Chief Executive Officer and President, will host the conference call.

About Auxilium Auxilium Pharmaceuticals, Inc.

is a specialty biopharmaceutical company with a focus on...

Market Wire:  Jul 17 2008 11:21AM
Matching: testim
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Announce Second Quarter 2008 Results and Conduct Conference Call on Thursday, July
Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the second quarter 2008 on Thursday, July 31, 2008 before the opening of the financial markets.

The Company will also conduct...

Calibre Macro World:  Jul 17 2008 11:16AM
Matching: testim
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Announce Second Quarter 2008 Results and Conduct Conference Call on Thursday, July
-- Auxilium Pharmaceuticals, Inc.

(NasdaqGM:AUXL - News), a specialty biopharmaceutical company, will release results for the second quarter 2008 on Thursday, July 31, 2008 before the opening of the financial markets.

The Company will...

Yahoo! Canada:  Jul 17 2008 11:13AM
Matching: testim
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Announce Second Quarter 2008 Results and Conduct Conference Call on Thursday, July
- Auxilium Pharmaceuticals, Inc.

(NASDAQ Mr.

Armando Anido, Chief Executive Officer and President, will host the conference call.

About Auxilium Auxilium Pharmaceuticals, Inc.

is a specialty biopharmaceutical company with a focus on...

Market Wire:  Jul 17 2008 11:08AM
Matching: testim
Find similar documents
HTML
100%
CPEX Pharmaceuticals Shares to Begin Trading Today Following Spin-off from Bentley Pharmaceuticals
EXETER, N.H.-- (BUSINESS WIRE) -- CPEX Pharmaceuticals, Inc.

(NASDAQ: CPEX) completed its previously announced taxable spin-off from Bentley Pharmaceuticals, Inc.

(NYSE: BNT) yesterday at 11:59 p.m.

Shares of the new company will begin...

SmartBrief:  Jul 2 2008 10:49PM
Matching: testim
Find similar documents
HTML
100%
Premium Company Profile - Auxilium Pharmaceuticals - New Research Report on Companies and Markets
Company-Profile/Premium-Comp ..

Introduction Auxiliums main focus is to develop and commercialize products for the treatment of health problems in the areas of urology and sexual health.

The company has only one marketed product, ...

PR inside:  Jul 2 2008 5:42PM
Matching: testim
Find similar documents
HTML
100%
Repros initiates Phase IIb study of oral male fertility drug
Enrollment of the 24 patients will commence at two sites in the New York City area shortly.

All subjects will have been previously diagnosed with secondary hypogonadism and treated with topical testosterone for at least six months but not...

Pharmaceutical Business Review:  Jul 2 2008 11:10AM
Matching: testim
Find similar documents
HTML
100%
Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal as Compared to Topical Testim
- Repros Therapeutics Inc.

(NasdaqGM:RPRX) reported today that the clinical sites have been initiated for its Phase 2b clinical study monitoring the effects of Repros' oral drug Androxal(R) on male fertility and testicular function in...

Pharma Live:  Jul 1 2008 9:24AM
Matching: testim
Find similar documents
HTML
100%
Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal(R) as Compared to Topical Tes
- Repros Therapeutics Inc.

(NasdaqGM:RPRX) reported today that the clinical sites have been initiated for its Phase 2b clinical study monitoring the effects of Repros' oral drug Androxal(R) on male fertility and testicular function in...

DiGiTAL50:  Jul 1 2008 5:46PM
Matching: testim
Find similar documents
HTML
100%
CPEX Pharmaceuticals Shares to Begin Trading Today Following Spin-off from Bentley Pharmaceuticals
Author : NH-CPEX/BENTLEY Category : Press Release News Alerts by Email click here ) News | Home EXETER, N.H.

- (Business Wire) CPEX Pharmaceuticals, Inc.

(NASDAQ: CPEX) completed its previously announced taxable spin-off from Bentley...

Earthtimes.org:  Jul 1 2008 1:09PM
Matching: testim
Find similar documents
HTML
100%
CPEX Pharmaceuticals Shares to Begin Trading Today Following
Stocks mentioned in this article Bentley Pharmaceuticals Inc (BNT) Stock Quote, Chart, News, Add to Watchlist CPEX Pharmaceuticals, Inc.

CPEX completed its previously announced taxable spin-off from Bentley Pharmaceuticals, Inc.

BNT...

Business Wire via MSN Money:  Jul 1 2008 12:56PM
Matching: testim
Find similar documents
HTML
100%
CPEX Pharmaceuticals Shares to Begin Trading Today Following Spin-off from Bentley Pharmaceuticals
EXETER, N.H.--(BUSINESS WIRE)--CPEX Pharmaceuticals, Inc.

(NASDAQ: CPEX - News) completed its previously announced taxable spin-off from Bentley Pharmaceuticals, Inc.

(NYSE: BNT - News) yesterday at 11:59 p.m.

Shares of the new company...

Yahoo! Canada:  Jul 1 2008 12:47PM
Matching: testim
Find similar documents
HTML
100%
Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal(R) as Compared to Topical Tes
, 6:00 AM EST News source: Business Wire Repros Therapeutics Inc.

(NasdaqGM:RPRX) reported today that the clinical sites have been initiated for its Phase 2b clinical study monitoring the effects of Repros' oral drug Androxal(R) on male...

Genetic Engineering News:  Jun 30 2008 10:42AM
Matching: testim
Find similar documents
HTML
100%
Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal as Compared to Topical Testim
- Repros Therapeutics Inc.

(NasdaqGM:RPRX) reported today that the clinical sites have been initiated for its Phase 2b clinical study monitoring the effects of Repros' oral drug Androxal(R) on male fertility and testicular function in...

Therapeutics Daily:  Jun 30 2008 12:41PM
Matching: testim
Find similar documents
HTML
100%
Auxilium Pharmaceuticals
(SkyNewswire.com)--MALVERN, PA--Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL) today announced that executive management will participate in the FBR Capital Markets 12th Annual Spring Investor Conference to be held May 28 - May 29, 2008 at...

SkyNewswire.com:  Jun 26 2008 8:14PM
Matching: testim
Find similar documents
HTML
100%
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Con
- Auxilium Pharmaceuticals, Inc.

(NASDAQ To listen to the audio web cast of the presentation during or after the event, please visit: http://www.auxilium.com.

The replay will be available for ninety days after the event.

About Auxilium...

Market Wire:  Jun 18 2008 12:27PM
Matching: testim
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL) today announced that executive management will participate in the Jefferies 2nd Annual Healthcare Conference to be held June 24 - June 26, 2008 at The Mandarin Oriental in New York City.

Macro World Investor:  Jun 18 2008 12:05PM
Matching: testim
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
-- Auxilium Pharmaceuticals, Inc.

(NasdaqGM:AUXL - News) today announced that executive management will participate in the Jefferies 2nd Annual Healthcare Conference to be held June 24 - June 26, 2008 at The Mandarin Oriental in New York...

Yahoo! Canada:  Jun 18 2008 11:59AM
Matching: testim
Find similar documents
HTML
100%
Auxilium Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
MALVERN, PA -- (MARKET WIRE) -- 06/18/08 -- Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL) today announced that executive management will participate in the Jefferies 2nd Annual Healthcare Conference to be held June 24 - June 26, 2008 at...

Street Insider:  Jun 18 2008 11:57AM
Matching: testim
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.